E-Mail
Concerns about side effects and whether vaccines have been through enough testing are holding people back from getting vaccinated against COVID-19, according to a new report.
Data from an international survey of 15 countries which ran between March and May this year showed that these were the most commonly cited reasons for not having had a coronavirus vaccine yet, in addition to not being eligible for one. Respondents other commonly reported reasons included concerns about not getting the vaccine they would prefer, and worries over whether the vaccines are effective enough.
Led by Imperial College London s Institute of Global Health Innovation in collaboration with YouGov, the survey also looked at trust in COVID-19 vaccines. Findings from over 68,000 people showed that there is variation across the world but overall, confidence is high with greater than 50% of respondents saying they trust coronavirus vaccines, except in South Korea and Japan (47%). People in the UK
For decades, researchers have debated whether the buildup of certain electrical activities in the brain indicates that human beings are unable to act out of free will. A new article argues that recent research undermines this case against free will.
Dr. Jirayut New Latthivongskorn and Dr. Denisse Rojas Marquez receive the 2021 Vilcek-Gold Award for Humanism in Healthcare. The award recognizes immigrant healthcare professionals in the United States whose work has a profound impact on public health and community-centered care.
June 5, 2021 marks the 40th anniversary of the first report of AIDS cases and the onset of the American AIDS epidemic. In a new, thought-provoking paper in the New England Journal of Medicine, Columbia professors capture the experiences of the physicians who were central to the AIDS epidemic. In the words of the doctors, they relay what it meant to look back after 40 years and how they aged together.
E-Mail
IMAGE: Dr. DeLuca, an expert in cognitive MS research, is senior vice president of Research and Training at Kessler Foundation. view more
Credit: Kessler Foundation
East Hanover, NJ. May 28, 2021. An international team of multiple sclerosis (MS) experts has identified four under-researched areas that are critical to advancing symptom management for progressive MS, recommending interdisciplinary collaboration among scientists, clinicians, industry leaders, and those with progressive MS. Their call to action was published in Multiple Sclerosis Journal on March 15, 2021, in the article Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance (doi: 10.1177/1352458521999970). The Alliance was represented by authors from Canada, the United States, the UK, Australia, Denmark, Belgium, Germany, and Switzerland.